Santé & Pharma

Liquidia Corp

5,8 Md

LivaNova PLC

4,3 Md

Lixte Biotechnology Holdings, INC.

57 M

LogicMark, Inc.

1,4 Md

Longeveron Inc.

23 M

Longeveron Inc.

24 M

Lonza Group AG

Lotus Eye Hospital and Institute Limited

2,3 Md

Lucid Diagnostics Inc.

189 M

Lucira Health, Inc.

Lumito AB (publ)

Lumito AB (publ)

Lumito AB (publikt)

Lumito AB (publikt)

Lumos Diagnostics Holdings Limited

91 M

Lumos Pharma, INC.

Lupin Limited

925 Md

Lyell Immunopharma, Inc.

296 M

Lyka Labs Limited

2,1 Md

Lyra Therapeutics, Inc.

1,4 M

Lytix Biopharma ASA

695 M

MAAT PHARMA

53 M

MABION S.A.

117 M

MAIA Biotechnology, Inc.

79 M

MANNKIND CORP

955 M

MAPS MAPS GROUP: IN THE FIRST HALF, STRONG GROWTH IN PRODUCTS DRIVEN BY THE HEALTHCARE SECTOR. CUSTOM PROJECTS RECORD A DECLINE

MAPS MAPS GROUP: THE TRANSITION TOWARDS PROPRIETARY SOFTWARE PRODUCTS CONTINUED IN 2025, DRIVEN BY HEALTHCARE

MAPS MAPS GROUP: THE TRANSITION TOWARDS PROPRIETARY SOFTWARE PRODUCTS CONTINUED IN 2025, DRIVEN BY HEALTHCARE

34 M

MARIA ISABEL LOZANO FERNANDEZ

MARIMED INC.

29 M

MASI AGRICOLA MASI AGRICOLA - C.S. ASSEMBLEA STRAORDINARIA DEL 04.03.2024

MASIMO CORP

9,4 Md

MBK Wellness Holdings株式会社

MEDICINOVA INC

68 M

MEDIFAST INC

135 M

MEDINCELL

967 M

MEDNAX, INC.

1,8 Md

MEDNAX, INC.

1,8 Md

MEI Pharma, Inc.

MERCK Kommanditgesellschaft auf Aktien

60 Md

MISONIX INC

MOLOGEN Lifescience AG

MPH Health Care AG

113 M

MPM Corpóreos S.A.

MSP Recovery, Inc.

MYOMO, INC.

60 M

Mabwell (Shanghai) Bioscience Co., Ltd. - B

17 Md

Macrogenics INC

249 M

Madrigal Pharmaceuticals, INC.

11 Md

Magellan Health INC